CHRISTOPHER THIESSEN: Open Payments
NPI 1306849914 · MOOSE LAKE, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$218 in 13 payments from 10 companies in 2025. Trend: 2023 $136 · 2024 $201 · 2025 $218
Food & beverage: $218
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $43 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Cepheid | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $7 |
Products named: Veozah, KEVEYIS, Belbuca, AIRSUPRA, Kerendia, CAPLYTA, BREZTRI, GeneXpert.
Industry payments across MN — which companies pay providers there.
